Xilinx Inc. v. Comm'r

125 T.C. No. 4, 125 T.C. 37, 2005 U.S. Tax Ct. LEXIS 24
CourtUnited States Tax Court
DecidedAugust 30, 2005
DocketNos. 4142-01, 702-03
StatusPublished
Cited by14 cases

This text of 125 T.C. No. 4 (Xilinx Inc. v. Comm'r) is published on Counsel Stack Legal Research, covering United States Tax Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Xilinx Inc. v. Comm'r, 125 T.C. No. 4, 125 T.C. 37, 2005 U.S. Tax Ct. LEXIS 24 (tax 2005).

Opinion

OPINION

Foley, Judge:

Respondent determined deficiencies in the amounts of $24,653,660, $25,930,531, $27,857,516, and $27,243,975 and section 6662(a) accuracy-related penalties in the amounts of $4,935,813, $5,189,389, $5,573,412, and $5,448,795 relating to petitioners’ 1996,1 1997, 1998, and 1999 Federal income taxes, respectively. The issues for decision are whether: (1) Petitioner and its foreign subsidiary must share the cost, if any, of stock options petitioner issued to research and development employees, (2) respondent’s allocations meet the arm’s-length requirement set forth in section 1.482-l(b), Income Tax Regs., and (3) petitioners are liable for section 6662(a) accuracy-related penalties.

Background

I. Xilinx’s Line of Business and Corporate Structure

Xilinx Inc.,2 is in the business of researching, developing, manufacturing, marketing, and selling field programmable logic devices,3 integrated circuit devices, and other development software systems. Petitioner uses unrelated producers to fabricate and assemble its wafers into integrated circuit devices.

During the years in issue, petitioner was the parent of a group of affiliated subsidiaries including, but not limited to Xilinx Holding One Ltd., Xilinx Holding Two Ltd., Xilinx Development Corp. (XDC), NeoCAD Inc.,4 Xilinx Ireland (XI), and Xilinx International Corp. XI was established in 1994 as an unlimited liability company under the laws of Ireland and was owned by Xilinx Holding One Ltd., and Xilinx Holding Two Ltd. (i.e., Irish subsidiaries of petitioner). XI was created to manufacture field programmable logic devices and to increase petitioner’s European market share. It manufactured, marketed, and sold field programmable logic devices, primarily to customers in Europe, and conducted research and development.

II. The Cost-Sharing Agreement

On April 2, 1995, petitioner and XI entered into a technology cost and risk sharing agreement (cost-sharing agreement). The cost-sharing agreement provided that all “New Technology” developed by either petitioner or XI would be jointly owned. New technology was defined as technology developed by petitioner, XI, or petitioner’s consolidated subsidiaries, on or after the execution date of the cost-sharing agreement. Each party was required to pay a percentage of the total research and development costs based on the respective anticipated benefits from new technology. The cost-sharing agreement further provided that each year the parties would review and, when appropriate, adjust such percentages to ensure that costs continued to be based on the anticipated benefits to each party.

Petitioner and XI were required to share direct costs, indirect costs, and acquired intellectual property rights costs. Direct costs were defined in the agreement as those costs directly related to the research and development of new technology including, but not limited to, salaries, bonuses, and other payroll costs and benefits. Indirect costs were defined as those costs, incurred by other departments, that generally benefit all research and development including, but not limited to, administrative, legal, accounting, and insurance costs. Acquired intellectual property rights costs were defined as costs incurred in connection with the acquisition of products or intellectual property rights. In determining the allocation of costs pursuant to the cost-sharing agreement, petitioner did not include in research and development costs any amount related to the issuance of employee stock options (ESOs).

Cost-sharing percentages for petitioner and XI relating to 1997, 1998, and 1999 were as follows:

Year Petitioner XI
1997 73.61% 26.39%
1998 73.35 26.65
1999 65.09 34.91

In 1997, 1998, and 1999, the following number of petitioner’s and XI’s employees engaged in research and development:

Year Petitioner XI
1997 CO CO 00 CD
1998 CO ^ CO O
1999 CO CO ^ CO rH

III. Petitioner s Stock Option Plans

ESOs are offers to sell stock at a stated price (i.e., the exercise price) for a stated period of time. They are used by many companies to attract, retain, and motivate employees and to align employee and employer goals. There are basically three types of ESOs: Statutory or incentive stock options (ISOs), nonstatutory stock options (NSOs), and purchase rights issued pursuant to an employee stock purchase plan (espp purchase rights). ISOs and NSOs allow employees to purchase stock at a fixed price for a specified period. ESPP purchase rights allow employees to purchase stock at a discount through the use of payroll deductions. ISOs and ESPP purchase rights receive special tax treatment and are typically not subject to tax when they are granted or exercised, but the stock acquired pursuant to the exercise of these options is subject to tax when such stock is sold.5 NSOs, however, are, pursuant to section 83,6 Property Transferred in Connection with the Performance of Services, subject to tax upon exercise unless the option has a readily ascertainable fair market value.7 Sec. 83(a). If an NSO has a readily ascertainable fair market value, income is recognized on the grant date, and the issuer is entitled to a deduction. Sec. 83(h); sec. 1.83-7(a), Income Tax Regs.

NSOS, when granted, may be “in-the-money”, “out-of-the-money”, or “at-the-money”. ISOs, however, may only be “at-the-money” or “out-of-the-money”.8 An option is deemed in-the-money when the exercise price on the grant date is below the stock’s market price. Conversely, an option is out-of-the-money when the exercise price on the grant date is above the stock’s market price. An option that has an exercise price equal to the stock’s market price on the grant date is considered at-the-money.

An employee typically cannot exercise options until the employee has a vested right (i.e., a legal right that is not contingent on the performance of additional services) in the option pursuant to the stock option plan’s terms. Some companies permit immediate vesting upon issuance of an option, while others delay vesting several years or allow incremental vesting over a period of years.

Petitioner, pursuant to broad-based plans (i.e., plans that offer ESOs to 20 percent or more of a company’s employees), offered three types of stock option compensation: ISOs, NSOs, and ESPP purchase rights. All ISOs and NSOs issued by petitioner were at-the-money. All ESPP purchase rights were issued with an exercise price equal to 85 percent of the stock’s market price. Prior to and during the 1997 taxable year, the options were generally subject to a 5-year vesting period. After 1997, petitioner decreased the vesting period from 5 to 4 years.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Altera Corp. v. Cir
Ninth Circuit, 2019
Medtronic, Inc. v. Comm'r
2016 T.C. Memo. 112 (U.S. Tax Court, 2016)
Bhutta v. Comm'r
145 T.C. No. 14 (U.S. Tax Court, 2015)
Altera Corp. v. Comm'r
145 T.C. No. 3 (U.S. Tax Court, 2015)
Veritas Software Corp. v. Comm'r
133 T.C. No. 14 (U.S. Tax Court, 2009)
Kim v. Comm'r
2007 T.C. Memo. 14 (U.S. Tax Court, 2007)
Xilinx Inc. and Subsidiaries v. Commissioner
125 T.C. No. 4 (U.S. Tax Court, 2005)
Xilinx Inc. v. Comm'r
125 T.C. No. 4 (U.S. Tax Court, 2005)

Cite This Page — Counsel Stack

Bluebook (online)
125 T.C. No. 4, 125 T.C. 37, 2005 U.S. Tax Ct. LEXIS 24, Counsel Stack Legal Research, https://law.counselstack.com/opinion/xilinx-inc-v-commr-tax-2005.